Nadège Gaborit

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR

Daniela A. Ferraro, Nadège Gaborit, Ruth Maron et al. · Proceedings of the National Academy of Sciences · 2013 · 110 citations · Full text

Breast Oncology, Oncology, Medicine +15

Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis

Laurent Grossin, Christel Henrionnet, Astrid Pinzano et al. · The FASEB Journal · 2006 · 74 citations

Tissue Engineering, Engineering, Immunology +22

Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers

Nadège Gaborit, Christel Larbouret, Julie Vallaghe et al. · Journal of Biological Chemistry · 2011 · 73 citations · Full text

In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption

Christel Larbouret, Nadège Gaborit, Thierry Chardès et al. · Neoplasia · 2012 · 68 citations · Full text

An oligoclonal antibody durably overcomes resistance of lung cancer to third‐generation <scp>EGFR</scp> inhibitors

Maicol Mancini, Hilah Gal, Nadège Gaborit et al. · EMBO Molecular Medicine · 2017 · 56 citations · Full text